Is NBIO or MO a better dividend investment in 2026?

NBIO currently yields 666666.67% with a 5% 5-year dividend growth rate. MO yields 6.36% with 4.3% growth. The better choice depends on your goal: NBIO offers higher current income.

What is the dividend yield difference between NBIO and MO?

NBIO has a forward dividend yield of 666666.67% ($2.00/share annually). MO yields 6.36% ($4.20/share annually). The yield gap is 666660.31 percentage points.

Home › Compare › NBIO vs MO

NBIO vs MO: Dividend Comparison 2026

NBIO yields 666666.67% · MO yields 6.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 NBIO wins by $8.275235618773884e+34M in total portfolio value

INVESTMENT

TIME HORIZON10 years

NBIO

● Live price

666666.67%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$8.275235618773884e+34M

Annual income

$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00

Full NBIO calculator →

Altria Group Inc.

● Live price

6.36%

Share price

$65.99

Annual div

$4.20

5Y div CAGR

22.6%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$80.1K

Annual income

$30,159.17

Full MO calculator →

Portfolio growth — NBIO vs MO

📍 NBIO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	NBIO	MO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, NBIO + MO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

NBIO pays

MO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NBIO

Annual income on $10K today (after 15% tax)

$56,666,666.67/yr

After 10yr DRIP, annual income (after tax)

$70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/yr

Annual income on $10K today (after 15% tax)

$540.99/yr

After 10yr DRIP, annual income (after tax)

$25,635.29/yr

At 15% tax rate, NBIO beats the other by $70,318,753,614,835,575,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NBIO + MO for your $10,000?

NBIO: 50%MO: 50%

100% MO50/50100% NBIO

Portfolio after 10yr

$4.137617809386942e+34M

Annual income

$41,363,972,714,609,160,000,000,000,000,000,000,000,000.00/yr

Blended yield

99.97%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

NBIO

No analyst data

Altman Z

-223.9

Piotroski

1/9

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$61.25

-7.2% upside vs current

Range: $47.00 — $68.00

Altman Z

3.2

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NBIO buys

MO buys

No recent congressional trades found for NBIO or MO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricNBIOMO

Forward yield	666666.67% ✓	6.36%
Annual dividend / share	$2.00	$4.20 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	22.6% ✓
Portfolio after 10y	$8.275235618773884e+34M	$80.1K ✓
Annual income after 10y	$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00 ✓	$30,159.17
Total dividends collected	$8.275075881065991e+34M	$74.5K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Staples

Year-by-year: NBIO vs MO ($10,000, DRIP)

Year	NBIO Portfolio	NBIO Income/yr	MO Portfolio	MO Income/yr	Gap
1← crossover	$66,677,367	$66,666,666.67	$10,570	$780.30	+$66.67M → NBIO
2	$415,506,651,117	$415,435,306,334.37	$11,381	$1,032.90	+$415506.64M → NBIO
3	$2,419,908,598,386,268	$2,419,464,006,269,573.00	$12,535	$1,392.73	+$2419908598.37M → NBIO
4	$13,171,697,643,084,456,000	$13,169,108,340,884,183,000.00	$14,193	$1,920.91	+$13171697643084.44M → NBIO
5	$67,004,927,492,790,120,000,000	$66,990,833,776,312,020,000,000.00	$16,618	$2,723.68	+$67004927492790120.00M → NBIO
6	$318,562,277,003,514,840,000,000,000	$318,490,581,731,097,560,000,000,000.00	$20,263	$3,993.80	+$318562277003514871808.00M → NBIO
7	$1,415,484,168,853,553,000,000,000,000,000	$1,415,143,307,217,159,200,000,000,000,000.00	$25,936	$6,098.36	+$1.415484168853553e+24M → NBIO
8	$5,878,130,573,362,507,000,000,000,000,000,000	$5,876,616,005,301,833,000,000,000,000,000,000.00	$35,166	$9,775.01	+$5.878130573362507e+27M → NBIO
9	$22,813,793,009,840,743,000,000,000,000,000,000,000	$22,807,503,410,127,248,000,000,000,000,000,000,000.00	$51,026	$16,597.78	+$2.2813793009840744e+31M → NBIO
10	$82,752,356,187,738,840,000,000,000,000,000,000,000,000	$82,727,945,429,218,320,000,000,000,000,000,000,000,000.00	$80,113	$30,159.17	+$8.275235618773884e+34M → NBIO

NBIO vs MO: Complete Analysis 2026

NBIO — Stock

Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a drug to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as epithelial cancers, including lung, breast, colon, brain, and pancreas cancer. In addition, the company is developing MultiPharm, a proprietary technology platform for cancer therapy, as well as diabetes, autoimmunity, and transplantation. Nascent Biotech, Inc. is based in Vero Beach, Florida.

Full NBIO Calculator →

MO — Consumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →

📬

Get this NBIO vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NBIO vs SCHD NBIO vs JEPI NBIO vs O NBIO vs KO NBIO vs MAIN NBIO vs PM NBIO vs BTI NBIO vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.